The commercial blind spot - Bridging the business gap for scientific founders

While scientific innovation drives breakthroughs in CGT, commercial understanding often determines whether those breakthroughs reach patients – and investors. This session will unpack why strong commercial acumen is just as critical as scientific excellence in securing funding and scaling successfully. Industry leaders and investors will discuss what scientific founders need to know about pricing, reimbursement, and market access, and how early commercial strategy can turn cutting-edge research into investable, sustainable businesses.

Key takeaways

• Why commercial acumen is just as important as scientific expertise
• How understanding pricing, reimbursement, and access can attract capital
• Practical ways to build commercial expertise within early-stage biotech teams